Niche Prenatal Focus Sequenom Laboratories specializes in molecular diagnostics for prenatal care, with branded tests like MaterniT21 and MaterniT Genome, indicating a target for partnerships with obstetricians, maternal-fetal medicine specialists, and genetic counselors.

Capable & Certified As a CAP-accredited and CLIA-certified lab offering LDTs, Sequenom can position itself as a high-quality, compliant partner for hospitals and clinics seeking validated genetic testing workflows and robust quality standards.

Expansion via NIPS Line Historical launches of MaterniT Genome NIPS and related tests suggest ongoing capability to expand noninvasive prenatal screening offerings, presenting opportunities to upsell broader genomic panels to current users.

Smaller Capable Partner With 11-50 employees and revenue in the mid tens of millions, Sequenom represents a nimble, cost-effective collaboration option for mid-market clinics and regional labs seeking specialized prenatal diagnostics without large-scale vendor commitments.

Market Positioning The company operates alongside larger genomic players but occupies a focused niche in prenatal molecular diagnostics, offering potential cross-sell opportunities with education on proprietary technologies and integration potential with existing obstetric workflows.